An Investigation of Plasma Collection, Stabilization, and Storage Procedures for Proteomic Analysis of Clinical Samples
Hulmes JD, Bethea D, Ho K, Huang S, Ricci DL, Opitek GJ, Hefta SA
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to assess the potential influence of the following processing variables on plasma proteomic analyses: storage duration and temperature, type of anticoagulant, presence of protease inhibitors, and freeze-thaw cycling.
Summary of Findings
Two-dimensional gel electrophoretic analysis revealed that refrigeration of blood specimens at 4 degrees C for 4-6 hours before centrifugation or after plasma separation did not significantly affect results, nor did frozen storage at -20 degrees C or 2 freeze-thaw cycles. However, storage of centrifuged non-separated specimens at 4 degrees C for 48 hours, or exclusion of protease inhibitors, resulted in significant derivations from controls processed and frozen immediately. Immunoassays for Placental Cadherin (PCAD) and soluble Vascular Adhesion Molecule-1 (sVCAM-1) similarly displayed significantly higher levels in specimens lacking protease inhibitors compared to controls.
Biospecimens
FluidPlasmaFluidBloodPreservation Types
FrozenDiagnoses
NormalPlatforms
Protein1D/2D gelsProteinImmunoassayPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Anticoagulant EDTALithium heparinBiospecimen Aliquots and Components Centrifugation Centrifugation delays investigatedStorage Freeze/thaw cycling 1 cycle2 cyclesStorage Storage duration 4-6 h48 hStorage Storage temperature -20 degrees C-70 degrees C4 degrees CAnalyte Extraction and Purification Protease inhibitor Cocktail